Company Directory

Enzymatic wound debridement therapy derived from maggot biology

SolasCure is a biotechnology company developing a recombinant enzyme-based hydrogel for the treatment of chronic wounds. The lead product contains a protease cloned from medical maggots that degrades non-viable wound tissue including fibrin, elastin, and collagen to prepare the wound bed for healing. The product is in Phase II clinical development for venous leg ulcers, with anti-biofilm activity as a secondary indication under investigation.

AI-powered microbiome and phage therapy platform for gut disorders

GutSee Health is a biotechnology company developing precision microbiome therapies for gut disorders including irritable bowel syndrome and inflammatory bowel disease. Its AI discovery platform integrates multi-omics and microbiome data to identify molecular disease signatures and therapeutic targets. A parallel programme uses machine learning to design targeted bacteriophage interventions that selectively remove harmful gut microbes and address antimicrobial-resistant wound infections.

Microbial and antimicrobial product developer using Bacillus fermentation

Genesis Biosciences is a global industrial biotechnology company developing and manufacturing microbial and antimicrobial products for cleaning, wastewater treatment, agriculture, aquaculture, and odour control applications. The company uses proprietary Bacillus fermentation and plant-derived actives to produce environmentally responsible alternatives to conventional chemical products. R&D and quality control are conducted at the Cardiff laboratory, with large-scale fermentation undertaken at the company's US facility.

Microbial and enzyme products for environmental biotechnology applications

Biological Preparations is a UK developer and manufacturer of bio-based products using microbial, enzyme, and plant extract technology. Its formulations address cleaning, disinfection, odour control, grease management, and wastewater treatment across industrial, agricultural, marine, and commercial sectors. The company applies bioremediation and bioaugmentation approaches, including in-house fermentation of nitrifying bacteria for wastewater treatment, replacing conventional chemical methods with sustainable alternatives. Customers include facility managers, manufacturers, water utilities, and agricultural operators.

Lab-grown human skin equivalent for cosmetic and pharmaceutical testing

Labskin is a contract research organisation offering preclinical testing services built around a proprietary full-thickness, lab-grown human skin equivalent. The model incorporates primary human keratinocytes and fibroblasts and is uniquely capable of hosting the skin's natural microflora, enabling microbiome-relevant testing unavailable on other in vitro platforms. Services span cosmetic efficacy and claims substantiation, pharmaceutical drug delivery, skin irritation, wound care, and antimicrobial testing. Clients include major global consumer health and skincare companies.

Microbiology and biofilm testing contract research organisation

5D Health Protection Group is a UK-based contract research and microbiology testing organisation providing antimicrobial, biofilm and infection control research services to healthcare, medical device and industrial clients. The company offers accredited laboratory testing, product evaluation and outsourced R&D support across areas including antimicrobial efficacy, biomaterials, tissue regeneration and diagnostics. 5D Health Protection Group supports product development and regulatory programmes through microbiology testing and specialist biofilm science expertise.

Anti-virulence drug discovery from natural bioactive compounds

Neem Biotech is a Wales-based drug discovery company developing novel non-traditional antimicrobial treatments derived from naturally inspired compounds. The company specialises in quorum sensing inhibitors and anti-biofilm agents, with programmes targeting wound infection and cystic fibrosis. Its discovery approach uses fragment screening coupled with expertise in bacterial-host interactions to identify small molecules that disrupt virulence rather than directly killing bacteria. Neem has spun out subsidiary Mariposa Therapeutics for keratin-related skin disorders.